Adage Capital Partners
ATYR

Adage Capital Partners’s aTyr Pharma ATYR Stock Holding History

Adage Capital Partners’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000,000
Closed -$3.62M – 960
2024
Q4 		$3.62M Hold
1,000,000
– – 0.01% 746
2024
Q3 		$1.76M Hold
1,000,000
– – ﹤0.01% 787
2024
Q2 		$1.56M Buy
+1,000,000
New +$1.74M ﹤0.01% 789

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners's ATYR Position: Q1 2025 in Review

Adage Capital Partners sold out of aTyr Pharma (ATYR) in Q1 2025, closing a stake of 1,000,000 shares — an estimated $3.62M sold.

Adage Capital Partners first reported a position in ATYR in Q2 2024 and held it in 3 quarters. The position peaked at $3.62M in Q4 2024. 87 funds tracked by Wall St. Rank hold ATYR as of Q1 2025.

  • Adage Capital Partners reported no remaining aTyr Pharma position as of Q1 2025 after selling out during the quarter.
  • Adage Capital Partners sold 1,000,000 aTyr Pharma shares in Q1 2025, an estimated $3.62M.
  • Adage Capital Partners first reported a position in aTyr Pharma in Q2 2024 and held it in 3 quarters.
  • Adage Capital Partners's aTyr Pharma position peaked at $3.62M in Q4 2024.
  • 87 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2025.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.